Oppenheimer analyst Jeff Jones reiterated an Outperform rating and $22.00 price target on Abeona Therapeutics (NASDAQ: ABEO)The analyst commented, "On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE